首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1508773

抗生素市场：依药物类型、频谱、给药途径、药物来源、地区

Antibiotics Market, By Drug Type, By Spectrum, By Route of Administration, By Drug Origin, By Geography

出版日期: 2024年05月31日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球抗生素市场规模为553.3亿美元，2031年将达782.4亿美元，2024年至2031年复合年增长率为5.1%。

图 1. 2024 年按地区分類的抗生素市场占有率(%)

全球抗生素市场在过去几十年中经历了稳定成长。感染疾病的流行以及抗生素抗药性细菌的增加，显着增加了对更新、更有效的抗生素药物的需求。此外，新兴市场医疗保健支出的增加以及支持抗生素开拓的有利法规环境也进一步支持了市场成长。然而，开发新抗生素的成本高昂以及缺乏创新管道是限制市场扩张的主要挑战。总体而言，由于抗药性感染疾病治疗的持续研究和开发，预计全球抗生素市场在未来几年将出现强劲成长。

市场动态：

全球抗生素市场是由全球感染疾病发病率上升和抗生素抗药性细菌增加所推动的。据世界卫生组织（WHO）称，抗菌素抗药性是全球健康面临的最大威胁之一，并对经济和发展构成严重威胁。抗生素抗药性的增加使得许多旧抗生素对新的致病菌株无效，因此需要新的治疗方法。这为药品製造商开发创新药物创造了重要机会。然而，开发新药所涉及的高成本和严格的监管程序是主要挑战。此外，缺乏新型抗生素管道以及对特种药物而非感染疾病的关注威胁着可持续增长。然而，透过官民合作关係支持抗生素研究和开发的倡议可以帮助克服这些障碍。

本研究的主要特点

本报告对全球抗生素市场进行了详细分析，并介绍了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
基于公司亮点、产品系列、主要亮点、财务表现和策略等参数的全球抗生素市场主要企业的概况。
主要企业包括雅培、赛诺菲、诺华、拜耳、葛兰素史克、阿斯特捷利康、Noreva Biotech、Emcure Pharmaceuticals、Torrent Pharma、Sun Pharmaceutical Industries Ltd.、Mylan NV、F. Hoffmann-La Roche Ltd. 和Merck & Co。
从这份报告中获得的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球抗生素市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球抗生素市场时使用的各种策略矩阵来促进决策。

The global antibiotics market has been witnessing steady growth over the past few decades. Rising prevalence of infectious diseases along with growing antibiotic resistance has considerably fueled the demand for newer and more effective antibiotic drugs. Moreover, increasing healthcare expenditure in developing nations and favorable regulatory environment supporting antibiotic development has further propelled the market growth. However, high development cost of novel antibiotics and lack of innovative pipeline are some of the major challenges restraining market expansion. Overall, the global antibiotics market is expected to witness robust growth in the coming years driven by ongoing R&D for the treatment of drug-resistant infections.

Market Dynamics:

The global antibiotics market is driven by the rising incidence of infectious diseases worldwide and growing antibiotic resistance. According to the World Health Organization, antimicrobial resistance is one of the biggest threats to global health posing a serious economic and development threat. Growing antibiotic resistance has rendered many older antibiotics ineffective against newer pathogenic strains requiring novel treatment options. This is creating significant opportunities for drug makers to develop innovative drugs. However, high costs involved in new drug development and stringent regulatory procedures are major challenges. Moreover, lack of novel antibiotic pipeline and focus on specialty medicines over infectious diseases threatens sustainable growth. However, initiatives supporting antibiotic R&D through public-private partnerships can help overcome these barriers.

Key Features of the Study:

This report provides an in-depth analysis of the global antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Abbott , Sanofi, Novartis AG, Bayer AG, GSK plc, AstraZeneca, Noreva Biotech, Emcure Pharmaceuticals, Torrent Pharma, Sun Pharmaceutical Industries Ltd., Mylan N.V., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Otsuka Pharmaceutical Co., Ltd., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global antibiotics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotics market.

Detailed Segmentation-

By Drug Type:
- Cephalosporins
- Penicillins
- Fluroquinilones
- Macrolides
- Carbapenems
- Sulfonamides
- Aminoglycosides
- Others
By Spectrum:
- Broad-Spectrum Antibiotics
- Narrow-Spectrum Antibiotics
By Route of Administration:
- Oral
- Intravenous
- Others
By Drug Origin:
- Natural
- Semisynthetic
- Artificial
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott
- Sanofi
- Novartis AG
- Bayer AG
- GSK plc
- AstraZeneca
- Noreva Biotech
- Emcure Pharmaceuticals
- Torrent Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Spectrum
- Market Snapshot, By Route of Administration
- Market Snapshot, By Drug Origin
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Antibiotics Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cephalosporins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Penicillins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Fluroquinilones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Macrolides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Carbapenems
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sulfonamides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Aminoglycosides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Antibiotics Market, By Spectrum, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Broad-Spectrum Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Narrow-Spectrum Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Antibiotics Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Antibiotics Market, By Drug Origin, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Natural
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Semisynthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Artificial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Antibiotics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Spectrum, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Origin, 2019 - 2031, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
- Novartis AG
- Bayer AG
- GSK plc
- AstraZeneca
- Noreva Biotech
- Emcure Pharmaceuticals
- Torrent Pharma
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

抗生素市场：依药物类型、频谱、给药途径、药物来源、地区